Skip to main content
. Author manuscript; available in PMC: 2021 Apr 12.
Published in final edited form as: Cancer Chemother Pharmacol. 2019 Mar 20;83(6):1025–1035. doi: 10.1007/s00280-019-03805-6

Figure 3. Changes in total and phospho- Src (A-D), total and phospho-EGFR (E-H) and total and phosphor-ErbB2 (I-L) protein levels from baseline.

Figure 3.

Waterfall plots on the left represent GD treatment arm and waterfall plots on the right represent GDC treatment arm.